Over the last 15 years, substantial progress has been made in understanding the potential and the limitations of the CA 125 assay. More than 2000 papers have been published concerning laboratory and clinical studies of CA 125. The original CA 125 assay utilized the OC 125 antibody that recognizes the CA 125 epitope on a…
The International Journal of Biological Markers Template
Write in a clean editor, then format for The International Journal of Biological Markers in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the The International Journal of Biological Markers format
The International Journal of Biological Markers is a peer-reviewed journal published by SAGE, covering Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', The International Journal of Biological Markers, 12(3), pp. 45–58.
Formats any DOI in The International Journal of Biological Markers style. No sign-up. |
| Publishes research in | Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research Glycosylation and Glycoproteins Research Protease and Inhibitor Mechanisms Colorectal Cancer Treatments and Studies |
| ISSN | 0393-6155 |
| Citation impact (2-yr) | 1.66 |
| h-index | 58 |
| i10-index | 1,003 |
| Total citations | 29,861 |
| Open access | Yes |
| Top institutions publishing here | Fondazione IRCCS Istituto Nazionale dei Tumori |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in The International Journal of Biological Markers per year
Citation impact of The International Journal of Biological Markers by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in The International Journal of Biological Markers
Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein and a member of the tyrosine kinase superfamily receptor. Gliomas are tumors originating from glial cells, which show a range of aggressiveness depending on grade and stage. Many EGFR gene alterations have been identified in gliomas, especially glioblastomas, including amplifications, deletions and single nucleotide polymorphisms (SNPs).…
Cathepsins B, H and L have been shown to participate in processes of tumor growth, vascularization, invasion and metastasis. Their levels in tumor tissue extracts can provide useful clinical information to predict disease-free and overall survival in breast, lung, colorectal, brain and head and neck cancer patients. Recently we have found that both cysteine cathepsins…
CA 15-3 (also known as MUC1) is the most widely used serum marker in breast cancer. MUC1 is a large transmembrane glycoprotein which is frequently overexpressed and aberrantly glycosylated in cancer. Physiologically, MUC1 appears to play a role in cell adhesion and the high levels present in cancer may be causally involved in metastasis. At…